Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine

Abstract

Anecdotal evidence suggests that ibogaine alleviates drug craving and relapse of drug use in humans, as has been confirmed for animals. Ibogaine is currently used as an antiaddiction drug in alternative medicine. In 1993, the Food and Drug Administration approved a clinical trial in humans to study those effects. The National Institute on Drug Abuse decided not to fund this study because of safety issues.

Sources

0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

©2012-2019 Global Ibogaine Therapy Alliance - Privacy Policy - Contact Us

or

Log in with your credentials

or    

Forgot your details?

or

Create Account